Fluid Biomarkers for Trial Enrichment and Effect Monitoring in Disease-Modifying Treatments for Parkinson Disease

Neurology. 2024 Mar 12;102(5):e209194. doi: 10.1212/WNL.0000000000209194. Epub 2024 Feb 5.

Authors

Lucilla Parnetti¹, Federico Paolini Paoletti¹

Affiliation

¹ From the Section of Neurology, Laboratory of Clinical Neurochemistry, Department of Medicine and Surgery, University of Perugia, Italy.

PMID: 38315967
DOI: 10.1212/WNL.0000000000209194

No abstract available

Publication types

Editorial

MeSH terms

Biomarkers
Disease Progression
Humans
Parkinson Disease* / drug therapy

Substances

Biomarkers